Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
leadXpro AG logo — Structure based drug discovery for membrane protein targets

leadXpro AG

Structure based drug discovery for membrane protein targets

Founded 2015 Switzerland Switzerland 32 employees

General Information

Company Name leadXpro AG
Founded Year 2015
Location Switzerland Switzerland +1
Employees 32
Social

Get notified when leadXpro AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About leadXpro AG

LeadXpro was founded in 2015 as a spin-out from the Paul Scherrer Institute (ETH) and is located between Zurich and Basel. The company aims to revolutionize the way drugs are being discovered for membrane proteins (e.g., GPCRs, ion channels, enzymes, transporters). These protein targets constitute more than half of the current drug targets but have not yet been fully amenable to structure-based drug design due to the considerable challenges in solving their atomic structures. To achieve our goal, we combine state-of-the-art methods for membrane protein science together with pioneering technologies in structural biology (Cryo-EM, XFEL). Our business model includes working in collaboration with Pharma/Biotech clients on their protein target of interest allowing them to keep their target exclusivity and all IP rights. We provide specialized expertise in areas such as construct design, protein generation, biophysical characterization of ligand interaction, crystallization, X-ray crystallography, electron microscopy and data analysis with computational methods. We also provide a lead discovery and optimization platform with the goal to deliver novel leads for challenging membrane protein targets. Find out more at www.leadxpro.com

No funding data available for leadXpro AG yet.

Get notified when leadXpro AG raises funding

leadXpro AG Alternatives & Competitors

leadXpro AG vs
OMass Therapeutics
OMass Therapeutics United Kingdom

OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, targeting complicated m...

Series B
78 employees
Life Sciences, Pharmaceutical
leadXpro AG vs
Immuto Scientific
Immuto Scientific United States

Breakthrough Technologies. Enabling Better Therapeutics.

Grant
16 employees
Biotechnology, Pharmaceutical
leadXpro AG vs
Sanoosa Pty. Ltd.
Sanoosa Pty. Ltd. Australia

We Computerize Drug Discovery

1 employees

FAQ About leadXpro AG

Structure based drug discovery for membrane protein targets
leadXpro AG was founded in 2015.
leadXpro AG is headquartered in Switzerland.
leadXpro AG has approximately 32 employees.
Top alternatives and competitors to leadXpro AG include OMass Therapeutics, Immuto Scientific, Sanoosa Pty. Ltd., InSingulo AB, NovaMechanics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
leadXpro AG and OMass Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors leadXpro AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy